12 Annual PEGS Europe Virtual Summit 2020
9 Nov – 12 Nov 2020
Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the virtual conference as a speaker on next Tuesday 10 November, in the session included in the section “Next generation ADCs”:
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
She will be also a moderator in the Panel Discussion that concludes the session “Improving the therapeutic index in ADCs”